The antioxidant effects of genistein are associated with AMP-activated protein kinase activation and PTEN induction in prostate cancer cells

Journal of Medicinal Food

Volumn 13, Issue 4, 2010, Pages 815-820

  Park, Chang Eun ^a   Yun, Hee ^a   Lee, Eun Byul ^a   Min, Byung Il ^a   Bae, Hyunsu ^b   Choe, Wonchae ^a   Kang, Insug ^a   Kim, Sung Soo ^a   Ha, Joohun ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

AMP activated protein kinase; catalase; genistein; phosphatase and tensin homolog deleted from chromosome 10; reactive oxygen species; superoxide dismutase

Indexed keywords

ADENOSINE PHOSPHATE; CATALASE; GENISTEIN; MANGANESE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TENSIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CHROMOSOME 10; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

AMP-ACTIVATED PROTEIN KINASES; ANTIOXIDANTS; CELL LINE, TUMOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; MALE; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE;

EID: 77955214065     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.1359     Document Type: Article

References (36)

1. Kondoh N, Imazeki N, Arai M, et al.: Activation of a system A amino acid transporter, ATA1/SLC38A1, in human hepatocellular carcinoma and preneoplastic liver tissues. Int J Oncol 2007;31:81-87.
2. Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS: Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst 1998;90:1637-1647
3. Jacobsen BK, Knutsen SF, Fraser GE: Does high soy milk intake reduce prostate cancer incidencé The Adventist health study (United States). Cancer Causes Control 1998;9:553-557.
4. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S: Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 2007;16:538-545. (Pubitemid 46548658)
5. Adlercreutz CH, Goldin BR, Gorbach SL, Höckerstedt KA, Watanabe S, Hämäläinen EK, Markkanen MH, Mäkelä TH, Wähälä KT, Adlercreutz T: Soybean phytoestrogen intake and cancer risk. J Nutr 1995;125(3 Suppl):757S-770S. Erratum in J Nutr 1995;125:1960.
6. Sarkar FH, Li Y: Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev 2002;21:265-280.
7. Waite KA, Sinden MR, Eng C: Phytoestrogen exposure elevates PTEN levels. Hum Mol Genet 2005;14:1457-1463.
8. Wang J, Eltoum IE, Carpenter M, Lamartiniere CA: Genistein mechanisms and timing of prostate cancer chemoprevention in Lobund-Wistar rats. Asian Pac J Cancer Prev 2009;10:143-150.
9. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-362.
10. Sulis ML, Parsons R: PTEN: from pathology to biology. Trends Cell Biol 2003;13:478-483.
11. Maehama T, Taylor GS, Dixon JE: PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem 2001; 70:247-279.
12. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW: Negative regulation of PKB=Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998;95:29-39.
13. Maehama T, Dixon JE: The tumor suppressor, PTEN=MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998;273:13375-13378.
14. Datta SR, Brunet A, Greenberg ME: Cellular survival: a play in three Akts. Genes Dev 1999;13:2905-2927.
15. Huo YY, Li G, Duan RF, Gou Q, Fu CL, Hu YC, Song BQ, Yang ZH, Wu DC, Zhou PK: PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts. Free Radic Biol Med 2008;44:1578-1591.
16. Marsin AS, Bouzin C, Bertrand L, Hue L: The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J Biol Chem 2002;277:30778-30783.
17. Choi SL, Kim SJ, Lee KT, Kim J, Mu J, Birnbaum MJ, Soo Kim S, Ha J: The regulation of AMP-activated protein kinase by H2O2. Biochem Biophys Res Commun 2001;287:92-97.
18. Hwang JT, Ha J, Park OJ: Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 2005;332:433-440.
19. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, Park OJ: Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005;338:694-699.
20. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG: Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 1996;271:27879-27887.
21. Malins DC, Johnson PM, Barker EA, Polissar NL, Wheeler TM, Anderson KM: Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors. Proc Natl Acad Sci USA 2003;100:5401-5406.
22. Fruehauf JP, Meyskens FL Jr: Reactive oxygen species: a breath of life or death? Clin Cancer Res 2007;13:789-794.
23. Jung SN, Yang WK, Kim J, Kim HS, Kim EJ, Yun H, Park H, Kim SS, Choe W, Kang I, Ha J: Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 2008;29:713-721.
24. Klaunig JE, Kamendulis LM: The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004;44:239-267.
25. BostwickDG, Alexander EE, Singh R, ShanA,Qian J, Santella RM, Oberley LW, Yan T, Zhong W, Jiang X, Oberley TD: Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 2000;89:123-134.
26. Banerjee S, Li Y, Wang Z, Sarkar FH: Multi-targeted therapy of cancer by genistein. Cancer Lett 2008;269:226-242.
27. Suzuki K, Koike H, Matsui H, Ono Y, Hasumi M, Nakazato H, Okugi H, Sekine Y, Oki K, Ito K, Yamamoto T, Fukabori Y, Kurokawa K, Yamanaka H: Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer 2002;99:846-852.
28. Cai Q, Wei H: Effect of dietary genistein on antioxidant enzyme activities in SENCA mice. Nutr Cancer 1996;25:1-7.
29. Stambolic V, Macpherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak TW: Regulation of PTEN transcription by p53. Mol Cell 2001;8:317-325.
30. Patel L, Pass I, Coxon P, Downes CP, Smith SA, Macphee CH: Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol 2001;11:764-768.
31. Virolle T,Adamson ED, Baron V, BirleD, Mercola D,Mustelin T, de Belle I: The Egr-1 transcription factor directly activates PTEN during irradiation-induced signaling. Nat Cell Biol 2001;3:1124-1128.
32. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor g (PPAR g). J Biol Chem 1995;270:12953-12956.
33. Han S, Roman J: Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgammaindependent signal pathways. Mol Cancer Ther 2006;5:430-437.
34. Teresi RE, Shaiu CW, Chen CS, Chatterjee VK, Waite KA, Eng C: Increased PTEN expression due to transcriptional activation of PPARgamma by lovastatin and rosiglitazone. Int J Cancer 2006;118:2390-2398.
35. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Löwik CW: Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 2003;278:962-967.
36. Cui W, Gu F, Hu KQ: Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 2009;15:1943-1950.